Abcuro

2 followers

Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class ant... Read more

Industries

Employees

11-50

Links


Org chart

Chief Executive Officer
Collapse
Chief Operating Officer
Chief Medical Officer
Director, Human Resources
Chief Financial Officer

Board & advisors

Chief Scientific Advisor and Chair, Medical Advisory Board
Observer
Director
Director
Director
Observer
Director
Board Observer
Observer
Chairman
Director